Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Bergmark

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Circulation|October 11, 2019
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 TrialBrian A Bergmark, Pieter W Kamphuisen, Stephen D Wiviott, et al.
The Journal of Invasive Cardiology|January 4, 2022
Practice Patterns in the Interventional Treatment of Coronary Bifurcation Lesions: A Global SurveyIlias Nikolakopoulos, Evangelia Vemmou, Judit Karacsonyi, et al.
Journal of the American College of Cardiology|February 12, 2025
Management of Coronary Stent UnderexpansionPrimero Ng, Akiko Maehara, Ajay J Kirtane, et al.
Journal of the American College of Cardiology|November 16, 2020
Effect of Evolocumab on Complex Coronary Disease Requiring RevascularizationKazuma Oyama, Remo H M Furtado, Antonio Fagundes, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2021
Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b designMarc P Bonaca, Richard T George, David A Morrow, et al.
Circulation. Cardiovascular Quality and Outcomes|June 3, 2024
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial FibrillationBrian A Bergmark, Jeong-Gun Park, Rose A Hamershock, et al.
American Heart Journal|March 10, 2025
Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemiaNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Circulation. Cardiovascular Interventions|February 25, 2022
Effect of Evolocumab in Patients With Prior Percutaneous Coronary InterventionRemo H M Furtado, Antônio Aurélio Fagundes, Kazuma Oyama, et al.
JAMA Cardiology|May 1, 2018
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical TrialBrian A Bergmark, Jacob A Udell, David A Morrow, et al.
The American Journal of Cardiology|June 7, 2017
Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent RestenosisFernanda M Mangione, Tannas Jatene, Roza Badr Eslam, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Circulation|October 11, 2019
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 TrialBrian A Bergmark, Pieter W Kamphuisen, Stephen D Wiviott, et al.
The Journal of Invasive Cardiology|January 4, 2022
Practice Patterns in the Interventional Treatment of Coronary Bifurcation Lesions: A Global SurveyIlias Nikolakopoulos, Evangelia Vemmou, Judit Karacsonyi, et al.
Journal of the American College of Cardiology|February 12, 2025
Management of Coronary Stent UnderexpansionPrimero Ng, Akiko Maehara, Ajay J Kirtane, et al.
Journal of the American College of Cardiology|November 16, 2020
Effect of Evolocumab on Complex Coronary Disease Requiring RevascularizationKazuma Oyama, Remo H M Furtado, Antonio Fagundes, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2021
Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b designMarc P Bonaca, Richard T George, David A Morrow, et al.
Circulation. Cardiovascular Quality and Outcomes|June 3, 2024
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial FibrillationBrian A Bergmark, Jeong-Gun Park, Rose A Hamershock, et al.
American Heart Journal|March 10, 2025
Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemiaNicholas A Marston, Brian A Bergmark, Veronica J Alexander, et al.
Circulation. Cardiovascular Interventions|February 25, 2022
Effect of Evolocumab in Patients With Prior Percutaneous Coronary InterventionRemo H M Furtado, Antônio Aurélio Fagundes, Kazuma Oyama, et al.
JAMA Cardiology|May 1, 2018
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical TrialBrian A Bergmark, Jacob A Udell, David A Morrow, et al.
The American Journal of Cardiology|June 7, 2017
Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent RestenosisFernanda M Mangione, Tannas Jatene, Roza Badr Eslam, et al.
Pageof 8